SUBSCRIBE
SUBSCRIBE

Alexion

NEWS
Scandal-Ridden Proove Biosciences Sells Assets, Founder and CEO Exits Amid Allegations
Business
Alexion CEO and CFO Abruptly Step Down, Former AstraZeneca PLC CEO Named New Leader
December 12, 2016
 · 
2 min read
Proteostasis and Roche Diagnostics Ink Huge Space in New Boston Hub
Deals
Canceled Appearance at Conference, Late 10Q Filing Fuel Alexion Acquisition Rumors
November 7, 2016
 · 
2 min read
Here’s Why 5 Billionaire-Led Funds Gobbled Up 3.3 Million Shares of Celldex Stock
Biotech Bay
Evaluation: 7 Biopharma Companies’ Market Value Based on Pipelines
July 14, 2016
 · 
3 min read
Genetown
Alexion’s Incredible Run Looks Far From Done
August 19, 2015
 · 
1 min read
Biogen Idec Alzheimer's Drug Aducanumab Exceeds Expectations
Deals
Alexion, BioMarin, Sanofi, Shire May Be Eyeing Dyax Corp. and Its Rare Genetic Disorder Drug
June 11, 2015
 · 
2 min read
Job Trends
200 Jobs Promised at Alexion Amid €450 Million Expansion
May 11, 2015
 · 
6 min read
Genetown
Alexion Investors May (In Time) Love Lofty Biotech Bid
May 7, 2015
 · 
1 min read
Astellas Pharma, Proteostasis Therapeutics Forge $1.2 Billion Genetic Disease Drug Development Pact
Business
Alexion Plunks Down $8.4 Billion for Synageva BioPharma, As Dealmaking Roars
May 6, 2015
 · 
6 min read
Astellas Pharma, Proteostasis Therapeutics Forge $1.2 Billion Genetic Disease Drug Development Pact
Deals
With Alexion Deal in Hand, Blueprint Medicines Preps for $100 Million IPO
March 24, 2015
 · 
4 min read
Load More
AWARDS
  • 2022 Best Places to Work
JOBS
IN THE PRESS
Press Releases
JCR Pharmaceuticals and Alexion Achieve Milestone in Collaborative Neurodegenerative Disease Program
September 22, 2025
 · 
4 min read
Press Releases
JCR Pharmaceuticals Enters License Agreement with Alexion for Proprietary JUST-AAV Capsids to be Used in the Development of Genomic Medicines
July 8, 2025
 · 
5 min read
Press Releases
Alexion, AstraZeneca Rare Disease reaches an agreement with the pan-Canadian Pharmaceutical Alliance (pCPA) for Koselugo (selumetinib) for the treatment of paediatric patients with neurofibromatosis type 1 (NF1) who have symptomatic, inoperable plexiform neurofibromas (PN)
December 18, 2024
 · 
5 min read
Press Releases
KOSELUGO® (selumetinib) Showed Significant and Clinically Meaningful Improvement in Objective Response Rate Versus Placebo in Adults With Neurofibromatosis Type 1 who Have Symptomatic, Inoperable Plexiform Neurofibromas in Global Phase 3 KOMET Trial
November 12, 2024
 · 
14 min read
Press Releases
Monopar Announces Agreement with Alexion, AstraZeneca Rare Disease For Late-Stage Wilson Disease Drug Candidate
October 25, 2024
 · 
8 min read
Business
AstraZeneca demonstrates commitment to patients living with amyloidosis at the 2024 International Symposium on Amyloidosis (ISA)
May 23, 2024
 · 
13 min read
Business
JCR Pharmaceuticals Announces Achievement of Milestone Using J-Brain Cargo® Technology for Neurodegenerative Disease in Research Collaboration with Alexion
March 19, 2024
 · 
4 min read
Drug Development
Long-term ALPHA Phase III trial data showed danicopan as add-on to ULTOMIRIS® or SOLIRIS® sustained clinical improvements in subset of patients with PNH experiencing clinically significant extravascular hemolysis
December 10, 2023
 · 
29 min read
Business
Verge Genomics Announces Artificial Intelligence-Enabled Drug Discovery Collaboration with Alexion for Rare Neurodegenerative and Neuromuscular Diseases
September 8, 2023
 · 
3 min read
BioCapital
Alexion advances commitment to transform patient outcomes in rare neurological diseases at AAN 2023
March 2, 2023
 · 
21 min read
Load More